세계의 경구 고형제(OSD) 수탁제조 시장(2024-2028년)

Global Oral Solid Dosage (OSD) Contract Manufacturing Market 2024-2028

US $ 2,500 ￦ 3,657,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,000 ￦ 5,852,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

경구 고형제(OSD) 수탁제조 시장은 2023-20281년에 142억 달러, 예측 기간 중 CAGR은 6.84%로 성장할 것으로 예측됩니다.

경구 고형제(OSD) 수탁제조 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.

현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 특허 만료와 제네릭 의약품의 수요 증가, 핵심 역량에 대한 주력 요구의 증가, 신흥 시장에서 비용 효율이 높은 리소스의 이용 가능성 등이 시장을 촉진하고 있습니다.

시장 범위
기준년	2024
종료년	2028
예측 기간	2024-2028
성장 모멘텀	가속
전년대비 2024년	6.35%
CAGR	6.84%
증분액	142억 달러

본 조사에서는 향후 수년간 경구 고형제(OSD) 수탁제조 시장 성장을 촉진하는 주요 요인의 하나로 미국 FDA 인가 제조 시설의 증가를 들고 있습니다. 또한 OSD를 제조하는 CMOS에 의한 애널리틱스의 이용이 확대하며, 시장 통합이 진행되는 것으로 이 시장은 큰 수요가 전망됩니다.

목차

제1장 개요

• 시장 개요

제2장 시장 구도

• 시장 에코시스템
• 시장 특징
• 밸류체인 분석

제3장 시장 규모의 평가

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 세계의 경구 고형제(OSD) 수탁제조 시장 2018-2022
• 최종사용자별 부문 분석 2018-2022
• 제품별 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제6장 시장 세분화 : 최종사용자별

• 시장 세분화
• 비교 : 최종사용자별
• 대기업 : 시장 규모와 예측 2023-2028
• 중소기업 : 시장 규모와 예측 2023-2028
• 신규 기업과 제네릭 의약품 기업 : 시장 규모와 예측 2023-2028
• 시장 기회 : 최종사용자별

제7장 시장 세분화 : 제품별

• 시장 세분화
• 비교 : 제품별
• 태블릿 : 시장 규모와 예측 2023-2028
• 캡슐 : 시장 규모와 예측 2023-2028
• 분말 : 시장 규모와 예측 2023-2028
• 과립제 등 : 시장 규모와 예측 2023-2028
• 시장 기회 : 제품별

제8장 고객 상황

• 고객 상황의 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 아시아 : 시장 규모와 예측 2023-2028
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 세계의 기타 지역 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 캐나다 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인·과제·기회·억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장의 기회·억제요인

제11장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계의 리스크

제12장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• AbbVie Inc.
• Aenova Holding GmbH
• Boehringer Ingelheim International GmbH
• Catalent Inc.
• Corden Pharma International GmbH
• Jubilant Pharmova Ltd.
• Lonza Group Ltd.
• Merck KGaA
• NextPharma GmbH
• Perkin Elmer Inc.
• Piramal Enterprises Ltd.
• Pyramid Laboratories Inc.
• Recipharm AB
• Siegfried Holding AG
• Thermo Fisher Scientific Inc.

제13장 부록

KSA

영문 목차

영문목차

The oral solid dosage (OSD) contract manufacturing market is forecasted to grow by USD 14.2 bn during 2023-2028, accelerating at a CAGR of 6.84% during the forecast period. The report on the oral solid dosage (OSD) contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by patent expiry and increasing demand for generic drugs, growing need to focus on core competencies, and availability of cost-efficient resources in emerging markets.

Technavio's oral solid dosage (OSD) contract manufacturing market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	6.35%
CAGR	6.84%
Incremental Value	$14.2 bn

By End-user

• Large-size companies
• Small and medium size companies
• Startups and generic pharmaceutical companies

By Product

• Tablets
• Capsules
• Powders
• Granules and others

By Geographical Landscape

• Asia
• North America
• Europe
• Rest of World (ROW)

This study identifies the increasing number of US FDA-approved manufacturing facilities as one of the prime reasons driving the oral solid dosage (OSD) contract manufacturing market growth during the next few years. Also, growing use of analytics by cmos that manufacture OSD and increasing market consolidation will lead to sizable demand in the market.

The report on the oral solid dosage (OSD) contract manufacturing market covers the following areas:

• Oral solid dosage (OSD) contract manufacturing market sizing
• Oral solid dosage (OSD) contract manufacturing market forecast
• Oral solid dosage (OSD) contract manufacturing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oral solid dosage (OSD) contract manufacturing market vendors that include AbbVie Inc., Acino International AG, Aenova Holding GmbH, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Catalent Inc., Corden Pharma International GmbH, Inglasia Pharma Solutions, Jubilant Pharmova Ltd., Koninklijke DSM NV, Lonza Group Ltd., Merck KGaA, NextPharma GmbH, Perkin Elmer Inc., Piramal Enterprises Ltd., Pyramid Laboratories Inc., Recipharm AB, Siegfried Holding AG, Thermo Fisher Scientific Inc., and Viatris Inc.. Also, the oral solid dosage (OSD) contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Oral Solid Dosage (OSD) Contract Manufacturing Market 2018 - 2022
  • Historic Market Size - Data Table on Global Oral Solid Dosage (OSD) Contract Manufacturing Market 2018 - 2022 ($ billion)
• 4.2 End-user segment analysis 2018 - 2022
  • Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• 4.3 Product segment analysis 2018 - 2022
  • Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 6.3 Large-size companies - Market size and forecast 2023-2028
  • Chart on Large-size companies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Large-size companies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Large-size companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Large-size companies - Year-over-year growth 2023-2028 (%)
• 6.4 Small and medium size companies - Market size and forecast 2023-2028
  • Chart on Small and medium size companies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Small and medium size companies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Small and medium size companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Small and medium size companies - Year-over-year growth 2023-2028 (%)
• 6.5 Startups and generic pharmaceutical companies - Market size and forecast 2023-2028
  • Chart on Startups and generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Startups and generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
  • Chart on Startups and generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Startups and generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by End-user
  • Market opportunity by End-user ($ billion)
  • Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Product

• 7.1 Market segments
  • Chart on Product - Market share 2023-2028 (%)
  • Data Table on Product - Market share 2023-2028 (%)
• 7.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 7.3 Tablets - Market size and forecast 2023-2028
  • Chart on Tablets - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Tablets - Market size and forecast 2023-2028 ($ billion)
  • Chart on Tablets - Year-over-year growth 2023-2028 (%)
  • Data Table on Tablets - Year-over-year growth 2023-2028 (%)
• 7.4 Capsules - Market size and forecast 2023-2028
  • Chart on Capsules - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Capsules - Market size and forecast 2023-2028 ($ billion)
  • Chart on Capsules - Year-over-year growth 2023-2028 (%)
  • Data Table on Capsules - Year-over-year growth 2023-2028 (%)
• 7.5 Powders - Market size and forecast 2023-2028
  • Chart on Powders - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Powders - Market size and forecast 2023-2028 ($ billion)
  • Chart on Powders - Year-over-year growth 2023-2028 (%)
  • Data Table on Powders - Year-over-year growth 2023-2028 (%)
• 7.6 Granules and others - Market size and forecast 2023-2028
  • Chart on Granules and others - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Granules and others - Market size and forecast 2023-2028 ($ billion)
  • Chart on Granules and others - Year-over-year growth 2023-2028 (%)
  • Data Table on Granules and others - Year-over-year growth 2023-2028 (%)
• 7.7 Market opportunity by Product
  • Market opportunity by Product ($ billion)
  • Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.4 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.5 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.8 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.9 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.10 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.11 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ billion)
  • Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
• 12.4 Aenova Holding GmbH
  • Aenova Holding GmbH - Overview
  • Aenova Holding GmbH - Product / Service
  • Aenova Holding GmbH - Key offerings
• 12.5 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
• 12.6 Catalent Inc.
  • Catalent Inc. - Overview
  • Catalent Inc. - Business segments
  • Catalent Inc. - Key offerings
  • Catalent Inc. - Segment focus
• 12.7 Corden Pharma International GmbH
  • Corden Pharma International GmbH - Overview
  • Corden Pharma International GmbH - Product / Service
  • Corden Pharma International GmbH - Key offerings
• 12.8 Jubilant Pharmova Ltd.
  • Jubilant Pharmova Ltd. - Overview
  • Jubilant Pharmova Ltd. - Business segments
  • Jubilant Pharmova Ltd. - Key news
  • Jubilant Pharmova Ltd. - Key offerings
  • Jubilant Pharmova Ltd. - Segment focus
• 12.9 Lonza Group Ltd.
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key news
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Segment focus
• 12.10 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
• 12.11 NextPharma GmbH
  • NextPharma GmbH - Overview
  • NextPharma GmbH - Product / Service
  • NextPharma GmbH - Key offerings
• 12.12 Perkin Elmer Inc.
  • Perkin Elmer Inc. - Overview
  • Perkin Elmer Inc. - Business segments
  • Perkin Elmer Inc. - Key news
  • Perkin Elmer Inc. - Key offerings
  • Perkin Elmer Inc. - Segment focus
• 12.13 Piramal Enterprises Ltd.
  • Piramal Enterprises Ltd. - Overview
  • Piramal Enterprises Ltd. - Product / Service
  • Piramal Enterprises Ltd. - Key offerings
• 12.14 Pyramid Laboratories Inc.
  • Pyramid Laboratories Inc. - Overview
  • Pyramid Laboratories Inc. - Product / Service
  • Pyramid Laboratories Inc. - Key offerings
• 12.15 Recipharm AB
  • Recipharm AB - Overview
  • Recipharm AB - Business segments
  • Recipharm AB - Key offerings
  • Recipharm AB - Segment focus
• 12.16 Siegfried Holding AG
  • Siegfried Holding AG - Overview
  • Siegfried Holding AG - Business segments
  • Siegfried Holding AG - Key offerings
  • Siegfried Holding AG - Segment focus
• 12.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations

관련자료